Teva Pharmaceutical Industries Ltd
TASE:TEVA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 533
6 982
|
| Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Teva Pharmaceutical Industries Ltd
Revenue Breakdown
Breakdown by Geography
Teva Pharmaceutical Industries Ltd
Breakdown by Segments
Teva Pharmaceutical Industries Ltd
|
Total Revenue:
15.8B
USD
|
|
Product:
13B
USD
|
|
North America Segment:
8.1B
USD
|
|
Europe Segment:
4.8B
USD
|
|
International Markets:
2B
USD
|
|
Distribution Service:
1.6B
USD
|
|
Generics Medicians:
1.6B
USD
|
|
Anda:
1.6B
USD
|
|
Austedo:
1.2B
USD
|
|
Other Activities:
926m
USD
|
|
License:
681m
USD
|
|
Product And Service, Other:
570m
USD
|
|
Other Products:
281m
USD
|
|
Respiratory Product:
265m
USD
|
|
Bendeka And Treanda:
241m
USD
|
|
Ajovy:
44m
USD
|
|
Copaxone:
39m
USD
|
You don't have any saved screeners yet
